Cargando...

Parathyroid Hormone Mediates Bone Growth through the Regulation of Osteoblast Proliferation and Differentiation

PTH (1–34) is the only FDA-approved anabolic agent for osteoporosis treatment in the U.S., but its mechanisms are not completely understood. This study investigated PTH effects on osteogenic cells at various stages of differentiation and proliferation using an engineered bone growth model in vivo. O...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pettway, Glenda J., Meganck, Jeffrey A., Koh, Amy J., Keller, Evan T., Goldstein, Steven A., McCauley, Laurie K.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2677418/
https://ncbi.nlm.nih.gov/pubmed/18234576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2007.11.017
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!